445 related articles for article (PubMed ID: 21680910)
1. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
2. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
Cook MB; Coburn SB; Lam JR; Taylor PR; Schneider JL; Corley DA
Gut; 2018 Mar; 67(3):418-529. PubMed ID: 28053055
[TBL] [Abstract][Full Text] [Related]
4. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database.
Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG
Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339
[TBL] [Abstract][Full Text] [Related]
5. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis.
Sarem M; Martínez Cerezo FJ; Salvia Favieres ML; Corti R
Gastroenterol Hepatol; 2023 Oct; 46(8):637-644. PubMed ID: 36243250
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.
Thota PN; Zackria S; Sanaka MR; Patil D; Goldblum J; Lopez R; Chak A
J Clin Gastroenterol; 2017; 51(5):402-406. PubMed ID: 27306940
[TBL] [Abstract][Full Text] [Related]
7. A predictive Bayesian network that risk stratifies patients undergoing Barrett's surveillance for personalized risk of developing malignancy.
Bradley A; Sami S; N G H; Macleod A; Prasanth M; Zafar M; Hemadasa N; Neagle G; Rosindell I; Apollos J
PLoS One; 2020; 15(10):e0240620. PubMed ID: 33045017
[TBL] [Abstract][Full Text] [Related]
8. Wide-area transepithelial sampling with computer-assisted analysis to detect high grade dysplasia and cancer in Barrett's esophagus: a multicenter randomized study.
van Munster SN; Leclercq P; Haidry R; Messmann H; Probst A; Ragunath K; Bhandari P; Repici A; Munoz-Navas M; Seewald S; Lemmers A; Fernández-Esparrach G; Pech O; Schoon EJ; Kariv R; Neuhaus H; Weusten BLAM; Siersema PD; Correale L; Meijer SL; de Hertogh G; Bergman JJGHM; Hassan C; Bisschops R
Endoscopy; 2023 Apr; 55(4):303-310. PubMed ID: 36150646
[TBL] [Abstract][Full Text] [Related]
9. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL
PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling.
Omidvari AH; Ali A; Hazelton WD; Kroep S; Lee M; Naber SK; Lauren BN; Ostvar S; Richmond E; Kong CY; Rubenstein JH; Lansdorp-Vogelaar I; Luebeck G; Hur C; Inadomi J
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):1961-1969. PubMed ID: 31816445
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China.
Gu J; Xie S; Wang S; Xue L; Zhou J; Li M; Fan Z; Chen R; Middleton DRS; Hao C; Wang J; Li B; Li X; Wei W
Int J Cancer; 2021 Nov; 149(9):1639-1648. PubMed ID: 34181269
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.
Cook MB; Thrift AP
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):1-26. PubMed ID: 33213789
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
Smith ZL; Thorgerson AM; Dawson AZ; Wani S
Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
[TBL] [Abstract][Full Text] [Related]
14. Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.
Di Caro S; Cheung WH; Fini L; Keane MG; Theis B; Haidry R; Di Renzo L; De Lorenzo A; Lovat L; Batterham RL; Banks M
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):251-60. PubMed ID: 26671515
[TBL] [Abstract][Full Text] [Related]
15. Impact of race/ethnicity and socioeconomic status on incident and prevalent esophageal cancer in patients with Barrett's esophagus.
Zhou MJ; Ladabaum U; Triadafilopoulos G; Clarke JO
Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37431107
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies.
Iyer PG; Codipilly DC; Chandar AK; Agarwal S; Wang KK; Leggett CL; Latuche LR; Schulte PJ
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2772-2779.e8. PubMed ID: 35217151
[TBL] [Abstract][Full Text] [Related]
17. Potential benefits of one‑time gastroscopy in search for precancerous conditions.
Romańczyk M; Ostrowski B; Barański K; Romańczyk T; Błaszczyńska M; Budzyń K; Didkowska J; Wojciechowska U; Hartleb M
Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 36602059
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis.
Kroep S; Heberle CR; Curtius K; Kong CY; Lansdorp-Vogelaar I; Ali A; Wolf WA; Shaheen NJ; Spechler SJ; Rubenstein JH; Nishioka NS; Meltzer SJ; Hazelton WD; van Ballegooijen M; Tramontano AC; Gazelle GS; Luebeck EG; Inadomi JM; Hur C
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1471-1474. PubMed ID: 28089850
[No Abstract] [Full Text] [Related]
19. Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma.
Garman KS; Ajayi TA; Boutte HJ; Chiu ST; von Furstenberg RJ; Lloyd BR; Zhang C; Onaitis MW; Chow SC; McCall SJ
PLoS One; 2020; 15(7):e0235906. PubMed ID: 32697782
[TBL] [Abstract][Full Text] [Related]
20. Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues.
Hyland PL; Hu N; Rotunno M; Su H; Wang C; Wang L; Pfeiffer RM; Gherman B; Giffen C; Dykes C; Dawsey SM; Abnet CC; Johnson KM; Acosta RD; Young PE; Cash BD; Taylor PR
PLoS One; 2014; 9(4):e93219. PubMed ID: 24714516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
